AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Cytokines stimulated by DNA vaccine against glutamic acid decarboxylase 65.

Vaccine Weekly

| July 16, 2003 | COPYRIGHT 2003 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

2003 JUL 16 - (NewsRx.com & NewsRx.net) -- Regulatory cytokine production was stimulated by DNA vaccination against an altered form of glutamic acid decarboxylase 65 in mice.

According to a study from Canada, "Nonobese diabetic (NOD) mice develop a T-cell dependent autoimmune form of diabetes, in which glutamic acid decarboxylase 65 (GAD65) is an important islet target antigen. Intramuscular DNA vaccination with a plasmid encoding native GAD65 (a cytosolic antigen) did not significantly alter the incidence of diabetes, but vaccination against an altered form of GAD65 with a signal peptide (spGAD), which is secreted in vitro, was protective."

"The preventive effect was further enhanced by repeated injections of the spGAD plasmid," said Yelena Glinka and colleagues at McGill University. "Following DNA injection into muscle GAD65 was expressed for several months, and this was not accompanied by an inflammatory response. Immunization against GAD65 was not associated with substantial alterations in cytokine production by splenic lymphocytes stimulated with immunogenic GAD65 peptides. In contrast, spGAD induced increased secretion of both interleukin 10 and interferon gamma and a striking decrease in the interferon gamma/interleukin 10 ratio in culture supernatants."

"Similarly, spGAD-immunized mice had higher serum interleukin 10 levels and lower serum ...

Related articles from newspapers, magazines, journals, and more
Glutamic acid decarboxylase peptide-specific T cells prevent type 1 diabetes.
Newspaper article from: World Disease Weekly December 28, 2004 700+ words
...NewsRx.net) -- Glutamic acid decarboxylase 65 peptide 206-220...diabetes transfer. "Glutamic acid decarboxylase (GAD) 65 is one of...diabetes transfer by glutamic acid decarboxylase 65 peptide 206-220...
Cerebellar Ataxia with Anti-glutamic Acid Decarboxylase Antibodies: A...
Newspaper article from: Neurology Alert April 1, 2001 700+ words
...Cerebellar Ataxia with Anti-glutamic Acid Decarboxylase Antibodies: A Potentially...Cerebellar ataxia with anti-glutamic acid decarboxylase antibodies. Arch Neurol...patients with antibodies to glutamic acid decarboxylase (GAD). Anti-GAD...
DNA vaccine encoding glutamic acid decarboxylase enhances diabetes.
Newspaper article from: Health & Medicine Week September 20, 2004 700+ words
...vaccination encoding glutamic acid decarboxylase can enhance insulitis...of plasmids encoding glutamic acid decarboxylase (GAD), a crucial beta...vaccination encoding glutamic acid decarboxylase can enhance insulitis...
Caloric restriction augments brain glutamic acid decarboxylase expression.
Newspaper article from: Obesity, Fitness & Wellness Week September 11, 2004 700+ words
...appears to augment brain glutamic acid decarboxylase-65 and-67 expression...increasing expression of glutamic acid decarboxylase (GAD), the rate...restriction augments brain glutamic acid decarboxylase-65 and-67 expression...
Cytokines stimulated by DNA vaccine against glutamic acid decarboxylase 65.
Newspaper article from: Drug Week July 18, 2003 700+ words
...against an altered form of glutamic acid decarboxylase 65 in mice. According...of diabetes, in which glutamic acid decarboxylase 65 (GAD65) is an important...against an altered form of glutamic acid decarboxylase 65 in nonobese diabetic...
Glutamic Acid Decarboxylase Repression Prevents Beta-Cell Destruction.
Newspaper article from: Gene Therapy Weekly December 6, 2001 700+ words
...medical writer - Repressing the expression of glutamic acid decarboxylase (GAD), an autoantigen, might be one way...Key points reported in this study include: * Glutamic acid decarboxylase (GAD) is an autoantigen that has been linked...
High prevalence of anti-glutamic acid decarboxylase (anti-GAD) antibodies in...
Archives of Environmental Health Langer, Pavel Tajtakova, Maria Guretzki, Hans-Joachim Kocan, Anton Petrik, Jan Chovancova, Jana Drobna, Beata Jursa, Stanislav Pavuk, Marian Trnovec, Tomas Sebokova, Elena Klimes, Iwar September 1, 2002 700+ words
...dependent diabetes (6,7); therefore, in the present study we determined retrospectively the prevalence of glutamic acid decarboxylase (anti-GAD) antibodies in aliquots of sera obtained during field surveys. Our primary goal was to glean...
Neurologix licenses GAD 65 gene from Diamyd.(Licensing agreements between...
Newspaper article from: Pharma Marketletter August 14, 2006 700+ words
...biotechnology firm Neurologix has secured a license from Sweden's Diamyd Medical granting it the use of the glutamic acid decarboxylase (GAD) 65 gene, which is a component of the core technology behind Neurologix' NLX-P101 gene therapy...
For more facts and information, see all results
©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA